SAP AG (NYSE: SAP) said it has announced a strategic collaboration with Stanford School of Medicine to research the contribution of genetics, environmental exposures, behavior and other factors to disease susceptibility using the power of the SAP HANA platform.
The company also announced its participation in the Global Alliance for Genomics and Health, a council of industry leaders working toward accelerating worldwide efforts to responsibly share and analyze large amounts of genomic and clinical data.
“SAP HANA has the potential to drive breakthrough innovation in genomics research and the healthcare industry overall,” said Barbara Stortz, senior vice president, SAP HANA Platform for Healthcare and SAP HANA Native Development, SAP AG. “It is a big step for SAP to closely collaborate with the Stanford School of Medicine and join the Global Alliance for Genomics and Health to ultimately enable a better understanding of genetic underpinnings of health and disease.”
As market leader in enterprise application software, SAP helps companies of all sizes and industries run better. For more information, visit www.sap.com.